HLS Therapeutics Inc. (TSX:HLS)
Canada
· Delayed Price · Currency is CAD 4.400
+0.060 (1.38%)
Apr 29, 2025, 9:56 AM EDT
HLS Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 17.46 | 21.95 | 20.72 | 21.18 | 20.61 | Upgrade
|
| Cash & Short-Term Investments | 17.46 | 21.95 | 20.72 | 21.18 | 20.61 | Upgrade
|
| Cash Growth | -20.48% | 5.93% | -2.15% | 2.75% | -56.22% | Upgrade
|
| Accounts Receivable | 6.72 | 9.64 | 8.91 | 9.77 | 10.92 | Upgrade
|
| Other Receivables | 0.8 | 1.05 | 2.29 | 1.74 | 1.58 | Upgrade
|
| Receivables | 7.53 | 10.69 | 11.19 | 11.51 | 12.5 | Upgrade
|
| Inventory | 9.06 | 9.53 | 8.9 | 8.93 | 10.63 | Upgrade
|
| Prepaid Expenses | 1.36 | 1.91 | 2.13 | 2.14 | 2.17 | Upgrade
|
| Other Current Assets | - | 0 | 1.43 | - | - | Upgrade
|
| Total Current Assets | 35.4 | 44.1 | 44.37 | 43.75 | 45.91 | Upgrade
|
| Property, Plant & Equipment | 1 | 0.97 | 1.13 | 1.57 | 1.38 | Upgrade
|
| Other Intangible Assets | 122.12 | 162.34 | 195.02 | 229.18 | 253.4 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.86 | 1.04 | 0.47 | 0.69 | 1.17 | Upgrade
|
| Other Long-Term Assets | 0.53 | 0.62 | 0.67 | 0.71 | 2.03 | Upgrade
|
| Total Assets | 159.9 | 209.06 | 241.65 | 275.91 | 303.91 | Upgrade
|
| Accounts Payable | 8.71 | 14.11 | 11.59 | 9.32 | 9.18 | Upgrade
|
| Accrued Expenses | - | - | - | - | 3.79 | Upgrade
|
| Current Portion of Long-Term Debt | 4.83 | 4.69 | 13.06 | 12 | 9.75 | Upgrade
|
| Current Portion of Leases | 0.46 | 0.46 | 0.53 | 0.61 | 0.39 | Upgrade
|
| Current Income Taxes Payable | 0.15 | 0.28 | - | 0.1 | 0.55 | Upgrade
|
| Other Current Liabilities | 8.4 | 7.14 | 6.02 | 5.65 | 11.98 | Upgrade
|
| Total Current Liabilities | 22.55 | 26.69 | 31.19 | 27.67 | 35.64 | Upgrade
|
| Long-Term Debt | 60.74 | 82.05 | 83.28 | 84.13 | 98.24 | Upgrade
|
| Long-Term Leases | 0.43 | 0.42 | 0.48 | 0.83 | 0.78 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 4.07 | 0.44 | 0.57 | 0.65 | - | Upgrade
|
| Other Long-Term Liabilities | 0.78 | 1.77 | 0.82 | 1.88 | - | Upgrade
|
| Total Liabilities | 88.56 | 111.36 | 116.33 | 115.17 | 134.66 | Upgrade
|
| Common Stock | 260.6 | 262.13 | 265.21 | 265.92 | 257.41 | Upgrade
|
| Additional Paid-In Capital | 15.14 | 13.87 | 13.82 | 11.72 | 11.39 | Upgrade
|
| Retained Earnings | -194.18 | -175.46 | -148.45 | -119.86 | -101.58 | Upgrade
|
| Comprehensive Income & Other | -10.21 | -2.84 | -5.26 | 2.96 | 2.02 | Upgrade
|
| Shareholders' Equity | 71.34 | 97.7 | 125.32 | 160.74 | 169.25 | Upgrade
|
| Total Liabilities & Equity | 159.9 | 209.06 | 241.65 | 275.91 | 303.91 | Upgrade
|
| Total Debt | 66.45 | 87.62 | 97.35 | 97.57 | 109.16 | Upgrade
|
| Net Cash (Debt) | -48.99 | -65.67 | -76.62 | -76.39 | -88.55 | Upgrade
|
| Net Cash Per Share | -1.54 | -2.04 | -2.36 | -2.37 | -2.79 | Upgrade
|
| Filing Date Shares Outstanding | 31.79 | 31.92 | 32.35 | 32.47 | 31.99 | Upgrade
|
| Total Common Shares Outstanding | 31.79 | 31.98 | 32.36 | 32.45 | 31.82 | Upgrade
|
| Working Capital | 12.86 | 17.41 | 13.18 | 16.08 | 10.27 | Upgrade
|
| Book Value Per Share | 2.24 | 3.05 | 3.87 | 4.95 | 5.32 | Upgrade
|
| Tangible Book Value | -50.78 | -64.65 | -69.7 | -68.45 | -84.16 | Upgrade
|
| Tangible Book Value Per Share | -1.60 | -2.02 | -2.15 | -2.11 | -2.64 | Upgrade
|
| Machinery | 1.18 | 1.17 | 1.12 | 1.08 | 1.03 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.